Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report

Fig. 2

Overview of the clinical course and treatment of autoimmune encephalitis in a 24-year-old male. While initially testing positive for AMPA receptor antibodies and subsequently for NMDA receptor antibodies, the patient tested positive for both AMPA and NMDA receptor antibodies approximately 3 months after his clinical presentation of encephalitis symptoms. CSF: cerebrospinal fluid, IVIG: intravenous immunoglobulin treatment, RTX: rituximab

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us